Background: Quinoa (Chenopodium quinoa Willd) is a gluten-free pseudocereal with high biological value protein, low glycemic carbohydrates, phytosterols and omega-3 and omega-6 fatty acids. It originated in the Andean region and has been consumed for thousands of years. Our objective was to assess blood cholesterol levels in coronary heart disease (CHD) patients in an outpatient clinic after the intake of processed quinoa seeds. Methods: This is a prospective study with twenty-seven patients, aged between 48 and 70 years (64.0 ± 8.4 yo), who were treated during 120 to 200 days. Blood samples were collected before and after the intake of quinoa seeds to determine the lipid profile of the group. Results: The results showed beneficial effects of the intake of quinoa with a significant reduction in total cholesterol (P=0.0008), triglycerides (P=0.001) and LDLc (P=0.008). Conclusions: The incorporation of quinoa in the eating routine can be considered beneficial in the prevention and control of risk factors for cardiovascular diseases, considered the major causes of death worldwide.
CITATION STYLE
Oliveira Silva, V., Lima GREGORIO, M., Fernando Villafanha, D., & Fernandes de Godoy, M. (2018). Effects of Intake of Processed Quinoa Seeds on Lipid Profile in Patients with Coronary Heart Disease. International Journal of Sciences, 4(03), 8–14. https://doi.org/10.18483/ijsci.1572
Mendeley helps you to discover research relevant for your work.